Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	phosphatidylinositol-3-phosphate binding	DAB2IP OBSCN ATG2A ZFYVE26 WIPI2	2.68e-05	48	147	5	GO:0032266
Domain	4_1_CTD	EPB41L3 EPB41L1 EPB41L2	1.98e-06	4	149	3	PF05902
Domain	SAB	EPB41L3 EPB41L1 EPB41L2	1.98e-06	4	149	3	PF04382
Domain	Band_4.1_C	EPB41L3 EPB41L1 EPB41L2	1.98e-06	4	149	3	IPR008379
Domain	SAB_dom	EPB41L3 EPB41L1 EPB41L2	1.98e-06	4	149	3	IPR007477
Domain	FA	EPB41L3 EPB41L1 EPB41L2	1.34e-04	13	149	3	PF08736
Domain	FERM-adjacent	EPB41L3 EPB41L1 EPB41L2	1.34e-04	13	149	3	IPR014847
Domain	FA	EPB41L3 EPB41L1 EPB41L2	1.34e-04	13	149	3	SM01195
Domain	-	DAB2IP DOCK11 OBSCN RGPD1 EPB41L3 TIAM2 TBC1D4 OSBPL6 EPB41L1 EPB41L2 GULP1	3.07e-04	391	149	11	2.30.29.30
Domain	-	COL6A6 MATN3 XRCC5 SEC24D INTS14	3.13e-04	74	149	5	3.40.50.410
Pubmed	Interaction network of human early embryonic transcription factors.	PSAP KMT2B ACACB RBBP5 ZNF423 RGPD1 BRMS1L BAZ1A ZNF644 SMARCD1 TAF1 KDM1A RAI1	5.18e-09	351	151	13	38297188
Pubmed	E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins.	KMT2B DOCK11 RBBP5 TOPAZ1 DISC1 OBSCN TIGD4 RNF213 STOX1 XRCC5 TBC1D4 UTP20 FBN3 EPB41L2 RAI1 SYMPK	1.49e-07	736	151	16	29676528
Pubmed	A central chaperone-like role for 14-3-3 proteins in human cells.	SORBS2 DSG2 DOCK11 TEX2 HJURP EPB41L3 YWHAE GLCCI1 CARD8 NEDD4 NHSL1 TBC1D4 OSBPL6 MTREX EDRF1 EPB41L1 EPB41L2	2.32e-07	861	151	17	36931259
Pubmed	Cardiac muscle cell cytoskeletal protein 4.1: analysis of transcripts and subcellular location--relevance to membrane integrity, microstructure, and possible role in heart failure.	EPB41L3 EPB41L1 EPB41L2	3.20e-07	4	151	3	15834631
Pubmed	Exome sequencing in seven families and gene-based association studies indicate genetic heterogeneity and suggest possible candidates for fibromuscular dysplasia.	MYLK OBSCN RNF213	3.20e-07	4	151	3	26147384
Pubmed	Neuron-specific protein network mapping of autism risk genes identifies shared biological mechanisms and disease-relevant pathologies.	DAB2IP SORBS2 ACACB TSPOAP1 CNST TEX2 USP9X RGPD1 MRPS27 PTEN EPB41L3 YWHAE RYR2 MAPK8IP3 NHSL1 SHANK2 POLD3 EPB41L1 EPB41L2	5.66e-07	1139	151	19	36417873
Pubmed	The functional landscape of Hsp27 reveals new cellular processes such as DNA repair and alternative splicing and proposes novel anticancer targets.	MYLK NEK10 XRCC5 EPB41L3 YWHAE LIG1 RAB43 EPB41L1 EPB41L2	6.74e-07	225	151	9	25277244
Pubmed	Band 4.1 proteins regulate integrin-dependent cell spreading.	EPB41L3 EPB41L1 EPB41L2	7.97e-07	5	151	3	22982319
Pubmed	Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.	DAB2IP SORBS2 DOCK11 USP9X RGPD1 XRCC5 EPB41L3 PEX5L YWHAE MAPK8IP3 NEDD4 SHANK2 LRP1 EPB41L1 KDM1A EPB41L2 RAI1	1.09e-06	963	151	17	28671696
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: II. The complete nucleotide sequences of 400 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	DAB2IP DHX16 SORBS2 TSPOAP1 ZNF423 NEDD4 ZNF644 MAPKBP1 MARCHF4 ST18 EPB41L1	1.83e-06	407	151	11	12693553
Pubmed	FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia.	ACACB COL6A6 DOCK11 TOPAZ1 USP9X MATN3 OBSCN MRPS27 HMMR EPB41L3 KDM1A RAI1	1.98e-06	497	151	12	36774506
Pubmed	A Large-scale genetic association study of esophageal adenocarcinoma risk.	DHX16 CYP1A1 CFTR RRM1 PTEN XRCC5 CARD8 TLR10 LIG1 PPARGC1B	3.43e-06	351	151	10	20453000
Pubmed	Synaptic GAP and GEF Complexes Cluster Proteins Essential for GTP Signaling.	DAB2IP SORBS2 USP9X EPB41L3 YWHAE NEDD4 SHANK2 EPB41L1 EPB41L2	4.19e-06	281	151	9	28706196
Pubmed	Structural diversity of band 4.1 superfamily members.	EPB41L3 EPB41L1 EPB41L2	4.42e-06	8	151	3	7983158
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	DAB2IP FLNC KMT2B OBSCN ATG2A TIAM2 MAPK8IP3 NHSL1 SHANK2 RAB43 TXNRD3 ZFYVE26 MAPKBP1 MYRF RAI1 HTT SYMPK	6.78e-06	1105	151	17	35748872
Pubmed	Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.	SPATA6 B3GALNT2 OBSCN RNF213 PTEN XRCC5 ARMC2 YWHAE CLCC1 MAPK8IP3 LRCH3 PPARGC1B TBC1D4 SHANK2 LRP1 IFT122 EPB41L1 RAI1 HTT GULP1	7.52e-06	1489	151	20	28611215
Pubmed	Comprehensive identification of phosphorylation sites in postsynaptic density preparations.	RGPD1 EPB41L3 PEX5L MAPK8IP3 NEDD4 SHANK2 EPB41L1 EPB41L2	8.24e-06	231	151	8	16452087
Pubmed	Genome-wide association analysis identifies susceptibility loci for migraine without aura.	LRP1 TRPM8 MARCHF4	9.41e-06	10	151	3	22683712
Pubmed	Long-term potentiation modulates synaptic phosphorylation networks and reshapes the structure of the postsynaptic interactome.	DAB2IP SORBS2 EPB41L3 YWHAE SHANK2 LRP1 EPB41L1 EPB41L2	1.50e-05	251	151	8	27507650
Pubmed	Proximity-dependent biotin identification (BioID) reveals a dynamic LSD1-CoREST interactome during embryonic stem cell differentiation.	KMT2B ACACB RGPD1 BRMS1L EPB41L3 TBC1D4 ZNF644 LRP1 TAF1 KDM1A	1.57e-05	418	151	10	34709266
Pubmed	RRM1-induced metastasis suppression through PTEN-regulated pathways.	RRM1 PTEN	1.87e-05	2	151	2	12687015
Pubmed	Metabolism of activated complement component C3 is mediated by the low density lipoprotein receptor-related protein/alpha(2)-macroglobulin receptor.	LRP1 C3	1.87e-05	2	151	2	10608878
Pubmed	NEDD4 Depletion Inhibits Hepatocellular Carcinoma Growth via Targeting PTEN.	PTEN NEDD4	1.87e-05	2	151	2	27467187
Pubmed	Non-enzymatic action of RRM1 protein upregulates PTEN leading to inhibition of colorectal cancer metastasis.	RRM1 PTEN	1.87e-05	2	151	2	25638032
Pubmed	Cystic Fibrosis Transmembrane Conductance Regulator Attaches Tumor Suppressor PTEN to the Membrane and Promotes Anti Pseudomonas aeruginosa Immunity.	CFTR PTEN	1.87e-05	2	151	2	29246444
Pubmed	Inhibitory regulation of cystic fibrosis transmembrane conductance regulator anion-transporting activities by Shank2.	CFTR SHANK2	1.87e-05	2	151	2	14679199
Pubmed	CFTR-PTEN-dependent mitochondrial metabolic dysfunction promotes Pseudomonas aeruginosa airway infection.	CFTR PTEN	1.87e-05	2	151	2	31270271
Pubmed	Phosphatase and tensin homolog deleted on chromosome 10 degradation induced by NEDD4 promotes acquired erlotinib resistance in non-small-cell lung cancer.	PTEN NEDD4	1.87e-05	2	151	2	28714370
Pubmed	Identification of a novel in-frame deletion in KCNQ4 (DFNA2A) and evidence of multiple phenocopies of unknown origin in a family with ADSNHL.	KCNQ4 PCDH15	1.87e-05	2	151	2	23443030
Pubmed	NRDE-2, the human homolog of fission yeast Nrl1, prevents DNA damage accumulation in human cells.	NRDE2 MTREX	1.87e-05	2	151	2	29902117
Pubmed	Epithelial myosin light chain kinase-dependent barrier dysfunction mediates T cell activation-induced diarrhea in vivo.	MYLK CFTR	1.87e-05	2	151	2	16184195
Pubmed	NRDE2 negatively regulates exosome functions by inhibiting MTR4 recruitment and exosome interaction.	NRDE2 MTREX	1.87e-05	2	151	2	30842217
Pubmed	LSD1 negatively regulates autophagy in myoblast cells by driving PTEN degradation.	PTEN KDM1A	1.87e-05	2	151	2	31806371
Pubmed	Myelinosomes act as natural secretory organelles in Sertoli cells to prevent accumulation of aggregate-prone mutant Huntingtin and CFTR.	CFTR HTT	1.87e-05	2	151	2	27493027
Pubmed	Oncogenic role of the E3 ubiquitin ligase NEDD4-1, a PTEN negative regulator, in non-small-cell lung carcinomas.	PTEN NEDD4	1.87e-05	2	151	2	20889565
Pubmed	The function of glutamatergic synapses is not perturbed by severe knockdown of 4.1N and 4.1G expression.	EPB41L1 EPB41L2	1.87e-05	2	151	2	19225127
Pubmed	Engulfment adaptor phosphotyrosine-binding-domain-containing 1 (GULP1) is a nucleocytoplasmic shuttling protein and is transactivationally active together with low-density lipoprotein receptor-related protein 1 (LRP1).	LRP1 GULP1	1.87e-05	2	151	2	23167255
Pubmed	Role of defective calcium regulation in cardiorespiratory dysfunction in Huntington's disease.	RYR2 HTT	1.87e-05	2	151	2	32897880
Pubmed	Mutant huntingtin downregulates myelin regulatory factor-mediated myelin gene expression and affects mature oligodendrocytes.	MYRF HTT	1.87e-05	2	151	2	25789755
Pubmed	A novel FLNC frameshift and an OBSCN variant in a family with distal muscular dystrophy.	FLNC OBSCN	1.87e-05	2	151	2	29073160
Pubmed	[Nedd4/PTEN in axonal branching].	PTEN NEDD4	1.87e-05	2	151	2	20819705
Pubmed	Deficiency of PTEN leads to aberrant chromosome segregation through downregulation of MAD2.	PTEN MAD2L1	1.87e-05	2	151	2	31545428
Pubmed	Functional interaction of phosphatase and tensin homologue (PTEN) with the E3 ligase NEDD4-1 during neuronal response to zinc.	PTEN NEDD4	1.87e-05	2	151	2	20100827
Pubmed	Is NEDD4-1 a negative regulator of phosphatase and tensin homolog in gastric carcinogenesis?	PTEN NEDD4	1.87e-05	2	151	2	23180960
Pubmed	Aagab acts as a novel regulator of NEDD4-1-mediated Pten nuclear translocation to promote neurological recovery following hypoxic-ischemic brain damage.	PTEN NEDD4	1.87e-05	2	151	2	33712741
Pubmed	Ubiquitination regulates PTEN nuclear import and tumor suppression.	PTEN NEDD4	1.87e-05	2	151	2	17218261
Pubmed	NEDD4-1 is a proto-oncogenic ubiquitin ligase for PTEN.	PTEN NEDD4	1.87e-05	2	151	2	17218260
Pubmed	Interaction of CED-6/GULP, an adapter protein involved in engulfment of apoptotic cells with CED-1 and CD91/low density lipoprotein receptor-related protein (LRP).	LRP1 GULP1	1.87e-05	2	151	2	11729193
Pubmed	Acetyl CoA Carboxylase 2 Is Dispensable for CD8+ T Cell Responses.	ACACB CD4	1.87e-05	2	151	2	26367121
Pubmed	ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1.	PSAP DSG2 B3GALNT2 DCBLD1 RANBP6 RNF213 RRM1 YWHAE CLCC1 DMXL1 KLHL11 FBLN1 TBC1D4 LRP1 UTP20 HTT SYMPK	1.98e-05	1201	151	17	35696571
Pubmed	Construction of long-transcript enriched cDNA libraries from submicrogram amounts of total RNAs by a universal PCR amplification method.	DAB2IP NRDE2 PRAMEF5 PSAP CNST TEX2 HJURP OBSCN GCNT2 TIAM2 INTS14 PAXBP1 BAZ1A WDFY1 PRAMEF6 NCKAP1L	2.13e-05	1084	151	16	11544199
Pubmed	Qualitative and quantitative analyses of protein phosphorylation in naive and stimulated mouse synaptosomal preparations.	DAB2IP TEX2 EPB41L3 PEX5L GLCCI1 MAPK8IP3 SHANK2 EPB41L1 HTT	2.25e-05	347	151	9	17114649
Pubmed	Protein interaction network of the mammalian Hippo pathway reveals mechanisms of kinase-phosphatase interactions.	SORBS2 ACACB DOCK11 USP9X EPB41L3 YWHAE LRCH3 TBC1D4 SMARCD1 MTREX	2.73e-05	446	151	10	24255178
Pubmed	Functional proteomics establishes the interaction of SIRT7 with chromatin remodeling complexes and expands its role in regulation of RNA polymerase I transcription.	DHX16 FLNC SRSF5 USP9X XRCC5 EPB41L3 UTP20 MTREX KDM1A EPB41L2 RAI1 SYMPK	3.04e-05	653	151	12	22586326
Pubmed	Impact of WIN site inhibitor on the WDR5 interactome.	KMT2B RBBP5 TAF1 HSF2	3.69e-05	43	151	4	33472061
Pubmed	Defining the proximal interaction networks of Arf GTPases reveals a mechanism for the regulation of PLD1 and PI4KB.	ACACB DSG2 CFAP36 RNF213 EPB41L3 CLCC1 RYR2 DMXL1 LIG1 SEC24D PWWP3A RELL1 EPB41L2	3.71e-05	777	151	13	35844135
Pubmed	Extracellular Hsp90α and clusterin synergistically promote breast cancer epithelial-to-mesenchymal transition and metastasis via LRP1.	SERPINA3 YWHAE LRP1 C3	4.05e-05	44	151	4	31273033
Pubmed	Crucial role of the C-terminus of PTEN in antagonizing NEDD4-1-mediated PTEN ubiquitination and degradation.	PTEN NEDD4	5.60e-05	3	151	2	18498243
Pubmed	Protein 4.1 expression in the developing hair cells of the mouse inner ear.	EPB41L3 EPB41L2	5.60e-05	3	151	2	19853587
Pubmed	ΔNp63α represses nuclear translocation of PTEN by inhibition of NEDD4-1 in keratinocytes.	PTEN NEDD4	5.60e-05	3	151	2	23589096
Pubmed	Possible involvement of NEDD4 in keloid formation; its critical role in fibroblast proliferation and collagen production.	PTEN NEDD4	5.60e-05	3	151	2	21986318
Pubmed	Regulation of PTEN degradation and NEDD4-1 E3 ligase activity by Numb.	PTEN NEDD4	5.60e-05	3	151	2	28437168
Pubmed	AS160 modulates aldosterone-stimulated epithelial sodium channel forward trafficking.	YWHAE TBC1D4	5.60e-05	3	151	2	20410134
Pubmed	Deciphering the Role of the rs2651899, rs10166942, and rs11172113 Polymorphisms in Migraine: A Meta-Analysis.	LRP1 TRPM8	5.60e-05	3	151	2	35454329
Pubmed	Isoforms of protein 4.1 are differentially distributed in heart muscle cells: relation of 4.1R and 4.1G to components of the Ca2+ homeostasis system.	EPB41L3 EPB41L2	5.60e-05	3	151	2	22429617
Pubmed	Global survey of organ and organelle protein expression in mouse: combined proteomic and transcriptomic profiling.	YWHAE TBC1D4	5.60e-05	3	151	2	16615898
Pubmed	Regulation of AMPA receptor GluR1 subunit surface expression by a 4. 1N-linked actin cytoskeletal association.	EPB41L1 EPB41L2	5.60e-05	3	151	2	11050113
Pubmed	LSD1 is required for chromosome segregation during mitosis.	KDM1A MAD2L1	5.60e-05	3	151	2	20189264
Pubmed	PUM2 promoted osteoarthritis progression through PTEN-mediated chondrocyte ferroptosis by facilitating NEDD4 mRNA degradation.	PTEN NEDD4	5.60e-05	3	151	2	38733337
Pubmed	Genetics of migraine in the age of genome-wide association studies.	LRP1 TRPM8	5.60e-05	3	151	2	22072275
Pubmed	Essential function of protein 4.1G in targeting of membrane protein palmitoylated 6 into Schmidt-Lanterman incisures in myelinated nerves.	EPB41L3 EPB41L2	5.60e-05	3	151	2	22025680
Pubmed	Customization of the translational complex regulates mRNA-specific translation to control CNS regeneration.	PTEN HTT	5.60e-05	3	151	2	37442131
Pubmed	High-expressing cystic fibrosis transmembrane conductance regulator interacts with histone deacetylase 2 to promote the development of Ph+ leukemia through the HDAC2-mediated PTEN pathway.	CFTR PTEN	5.60e-05	3	151	2	28235656
Pubmed	Rak functions as a tumor suppressor by regulating PTEN protein stability and function.	PTEN NEDD4	5.60e-05	3	151	2	19345329
Pubmed	PTEN inhibits IL-2 receptor-mediated expansion of CD4+ CD25+ Tregs.	PTEN CD4	5.60e-05	3	151	2	16917540
Pubmed	Extracellular HMGB1 Impairs Macrophage-Mediated Efferocytosis by Suppressing the Rab43-Controlled Cell Surface Transport of CD91.	RAB43 LRP1	5.60e-05	3	151	2	35392093
Pubmed	Relevance of insulin-like growth factor 2 in the etiopathophysiology of diabetic nephropathy: possible roles of phosphatase and tensin homolog on chromosome 10 and secreted protein acidic and rich in cysteine as regulators of repair.	SPARC PTEN	5.60e-05	3	151	2	20929508
Pubmed	LINC01198 promotes proliferation and temozolomide resistance in a NEDD4-1-dependent manner, repressing PTEN expression in glioma.	PTEN NEDD4	5.60e-05	3	151	2	31469661
Pubmed	Genome-wide association study reveals three susceptibility loci for common migraine in the general population.	LRP1 TRPM8	5.60e-05	3	151	2	21666692
Pubmed	Impaired NMDA receptor transmission alters striatal synapses and DISC1 protein in an age-dependent manner.	DISC1 YWHAE	5.60e-05	3	151	2	21436042
Pubmed	WDR76 Co-Localizes with Heterochromatin Related Proteins and Rapidly Responds to DNA Damage.	RBBP5 BRMS1L XRCC5 INTS14 BAZ1A SMARCD1 TAF1 EPB41L2 RAI1	6.02e-05	394	151	9	27248496
Pubmed	Prediction of the coding sequences of unidentified human genes. XI. The complete sequences of 100 new cDNA clones from brain which code for large proteins in vitro.	SORBS2 ZNF423 ATP10B CLCC1 SEC24D	8.18e-05	101	151	5	9872452
Pubmed	Four paralogous protein 4.1 genes map to distinct chromosomes in mouse and human.	EPB41L3 EPB41L1 EPB41L2	8.66e-05	20	151	3	9828140
Pubmed	Combinatorial targeting of a chromatin complex comprising Dot1L, menin and the tyrosine kinase BAZ1B reveals a new therapeutic vulnerability of endocrine therapy-resistant breast cancer.	KMT2B SRSF5 DSG2 RBBP5 MRPS27 XRCC5 YWHAE PAXBP1 BAZ1A SMARCD1 UTP20 MTREX SYMPK	8.86e-05	847	151	13	35850772
Pubmed	Prediction of the coding sequences of unidentified human genes. IX. The complete sequences of 100 new cDNA clones from brain which can code for large proteins in vitro.	DHX16 TBC1D4 MAPKBP1 ST18 KDM1A	9.83e-05	105	151	5	9628581
Pubmed	[Expression of Gemcitabine-resistance-related gene and polymorphism of ribonucleotide reductase M1 gene promoter in Gemcitabine-resistant A549/Gem and NCI-H460/Gem cell lines].	RRM1 PTEN	1.12e-04	4	151	2	20211060
Pubmed	Apolipoprotein E2 Stimulates Protein Synthesis and Promotes Melanoma Progression and Metastasis.	PTEN LRP1	1.12e-04	4	151	2	37335131
Pubmed	The ubiquitin ligase Nedd4-1 is dispensable for the regulation of PTEN stability and localization.	PTEN NEDD4	1.12e-04	4	151	2	18562292
Pubmed	PTEN phosphorylation and nuclear export mediate free fatty acid-induced oxidative stress.	PTEN NEDD4	1.12e-04	4	151	2	24063548
Pubmed	YY1-regulated LINC00152 promotes triple negative breast cancer progression by affecting on stability of PTEN protein.	PTEN NEDD4	1.12e-04	4	151	2	30594392
Pubmed	Long non-coding RNA AWPPH enhances malignant phenotypes in nasopharyngeal carcinoma via silencing PTEN through interacting with LSD1 and EZH2.	PTEN KDM1A	1.12e-04	4	151	2	32663416
Pubmed	Activation of 3-phosphoinositide-dependent kinase 1 (PDK1) and serum- and glucocorticoid-induced protein kinase 1 (SGK1) by short-chain sphingolipid C4-ceramide rescues the trafficking defect of ΔF508-cystic fibrosis transmembrane conductance regulator (ΔF508-CFTR).	CFTR NEDD4	1.12e-04	4	151	2	25384981
Pubmed	Adipose tissue gene expression of factors related to lipid processing in obesity.	LRP1 C3	1.12e-04	4	151	2	21966368
Pubmed	The E3 Ubiquitin Ligase NEDD4-1 Mediates Temozolomide-Resistant Glioblastoma through PTEN Attenuation and Redox Imbalance in Nrf2-HO-1 Axis.	PTEN NEDD4	1.12e-04	4	151	2	34638586
Pubmed	DISC1 regulates new neuron development in the adult brain via modulation of AKT-mTOR signaling through KIAA1212.	DISC1 PTEN	1.12e-04	4	151	2	19778506
Pubmed	Two Nedd4-binding motifs underlie modulation of sodium channel Nav1.6 by p38 MAPK.	NEDD4 CD4	1.12e-04	4	151	2	20530479
Pubmed	Complement receptor 3 (CD11b/CD18) is implicated in the elimination of β-amyloid peptides.	LRP1 C3	1.12e-04	4	151	2	20199584
Pubmed	Silencing of PMEPA1 accelerates the growth of prostate cancer cells through AR, NEDD4 and PTEN.	PTEN NEDD4	1.12e-04	4	151	2	25883222
Pubmed	Plk1 phosphorylation of PTEN causes a tumor-promoting metabolic state.	PTEN NEDD4	1.12e-04	4	151	2	25047839
Pubmed	ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing.	MYLK DSG2 PTEN RYR2	1.13e-04	57	151	4	23788249
GeneFamily	Erythrocyte membrane protein band 4.1\|FERM domain containing	EPB41L3 EPB41L1 EPB41L2	5.25e-07	4	93	3	951
GeneFamily	WD repeat domain containing	RBBP5 DMXL1 WDR97 IFT122 MAPKBP1 WIPI2 WDFY1	4.06e-04	262	93	7	362
Coexpression	GSE2405_HEAT_KILLED_LYSATE_VS_LIVE_A_PHAGOCYTOPHILUM_STIM_NEUTROPHIL_9H_UP	DAB2IP PSAP HMMR EPB41L3 GLCCI1 LIG1 LRP1 C3 MAD2L1	2.44e-06	199	151	9	M6198
Coexpression	GSE36476_YOUNG_VS_OLD_DONOR_MEMORY_CD4_TCELL_UP	DPYS SORBS2 TSPOAP1 ATG2A NEDD4 KLHL11 SEC24D IFI44L	1.82e-05	195	151	8	M5306
Coexpression	GSE39556_UNTREATED_VS_3H_POLYIC_INJ_MOUSE_NK_CELL_DN	MYLK SRSF5 RANBP6 MAPK8IP3 NEDD4 RGL1 KCNS3 MYRF	2.18e-05	200	151	8	M9411
ToppCell	RV\|World / Chamber and Cluster_Paper	KLHL24 SORBS2 ACACB NEK10 OBSCN GCNT2 TMEM132C PPARGC1B TBC1D4	1.22e-08	181	151	9	bbe1e6e59d8889bd37d6e8303116cbdcafca7236
ToppCell	RV-06._Ventricular_Cardiomyocyte_II\|World / Chamber and Cluster_Paper	KLHL24 SORBS2 ACACB NEK10 OBSCN GCNT2 RYR2 PPARGC1B TBC1D4	1.78e-08	189	151	9	5e80c47f63980904c4c1ff02c201b67b456a0974
ToppCell	PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	MYLK SPATA6 COL6A6 NKAIN2 TMEM132C FBLN1 LRP1 EPB41L2 GULP1	2.66e-08	198	151	9	17dc055e2a289496d9c5cdbf3297bdf906dc6d22
ToppCell	5'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophages-Alveolar_macrophages_L.1.0.5.0\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	MIS18BP1 PSAP DOCK11 RNF213 EPB41L3 LRP1 ZFYVE26 NCKAP1L	1.48e-07	174	151	8	d5c22b43531414951666ee7542a66ed9380e2d14
ToppCell	LPS-IL1RA+antiTNF\|World / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	SORBS2 EPB41L3 TMEM132C FBLN1 TBC1D4 SHANK2 IRX2 GULP1	1.68e-07	177	151	8	b7fee75de7e96924af488a5baa2334711889ae7c
ToppCell	RV-04._Ventricular_Cardiomyocyte_I\|World / Chamber and Cluster_Paper	KLHL24 SORBS2 ACACB NEK10 OBSCN GCNT2 PPARGC1B TBC1D4	2.56e-07	187	151	8	78cdcf8bc141d3b155c3c8af908431fc419c4d08
ToppCell	Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell-D150\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	DPYS MYLK SPATA6 NKAIN2 TMEM132C FBLN1 PCDH15 GULP1	2.78e-07	189	151	8	203c80030df08ae112f9ae4043709f455d87ce89
ToppCell	LV-06._Ventricular_Cardiomyocyte_II\|World / Chamber and Cluster_Paper	KLHL24 SORBS2 ACACB NEK10 OBSCN GCNT2 RYR2 TBC1D4	2.89e-07	190	151	8	de5ef606a002f85c2e0e3a36c1f259d0b85a76ff
ToppCell	LV-06._Ventricular_Cardiomyocyte_II\|LV / Chamber and Cluster_Paper	KLHL24 SORBS2 ACACB NEK10 OBSCN GCNT2 RYR2 TBC1D4	3.01e-07	191	151	8	25f3eb34f4e70761e81e84c8a5829f216108cbc6
ToppCell	LPS-IL1RA+antiTNF-Stromal_mesenchymal\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	MYLK COL6A6 RYR2 TMEM132C FBLN1 PCDH15 LRP1 GULP1	3.13e-07	192	151	8	3d0cb19f037f604253d7d728689aeaa94251e92b
ToppCell	PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	MYLK SPATA6 COL6A6 TMEM132C FBLN1 LRP1 EPB41L2 GULP1	3.67e-07	196	151	8	1450cb69c5bf469e97c03bf1890f6f7c54165b8a
ToppCell	PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature3_(17)\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	MYLK SPATA6 NKAIN2 TMEM132C FBLN1 LRP1 EPB41L2 GULP1	3.81e-07	197	151	8	31a1852911bda38543916585fda34255fd62a134
ToppCell	Fetal_brain-fetalBrain_Zhong_nature-GW26-OPC_related-OPC\|GW26 / Sample Type, Dataset, Time_group, and Cell type.	SPARC SPATA6 HJURP ATP10B HMMR PCDH15 EPB41L2 MAD2L1	4.27e-07	200	151	8	02594c1edbc9f2cf831639cd83363abd2551cb94
ToppCell	Fetal_brain-fetalBrain_Zhong_nature-GW26-OPC_related\|GW26 / Sample Type, Dataset, Time_group, and Cell type.	SPARC SPATA6 HJURP ATP10B HMMR PCDH15 EPB41L2 MAD2L1	4.27e-07	200	151	8	46521d83b917b0357601db8783c8da6b73730d60
ToppCell	Bronchial-NucSeq-Immune_Myeloid-Macrophage_other\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	PSAP DISC1 EPB41L3 RGL1 PPARGC1B LRP1 ST18 NCKAP1L	4.27e-07	200	151	8	78d75d381cb2b9a4c9eb7c32a07b014eaee39195
ToppCell	COVID-19-Heart-CM_+_Macrophage\|Heart / Disease (COVID-19 only), tissue and cell type	FLNC SORBS2 OBSCN RYR2 CD4 DDX60L NCKAP1L	1.90e-06	170	151	7	4232fe937909f93d3736988c707b8f95ce993398
ToppCell	356C-Fibroblasts-Fibroblast-G\|356C / Donor, Lineage, Cell class and subclass (all cells)	SERPINA3 SPARC MYLK COL6A6 RYR2 FBLN1 PCDH15	2.48e-06	177	151	7	8220cc2fc0ee8764a67a3be51d75248be2453040
ToppCell	356C-Fibroblasts-Fibroblast-G-\|356C / Donor, Lineage, Cell class and subclass (all cells)	SERPINA3 SPARC MYLK COL6A6 RYR2 FBLN1 PCDH15	2.48e-06	177	151	7	7617270f49cd6b7ba66db72d20560cee985012b2
ToppCell	droplet-Spleen-nan-3m-Lymphocytic-immature_NKT_cell\|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MIS18BP1 TTLL9 RRM1 LIG1 FBLN1 CD4 MAD2L1	2.67e-06	179	151	7	54621d2b3a66e62aa76b7e444118878ed97c1e02
ToppCell	Control-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	MATN3 RYR2 TMEM132C FBLN1 PCDH15 LRP1 MARCHF4	2.77e-06	180	151	7	08ae0f5d95c45feba68ad99788f7af7ff4c979af
ToppCell	Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D046\|Children_(3_yrs) / Lineage, Cell type, age group and donor	DPYS MYLK COL6A6 RYR2 TMEM132C FBLN1 PCDH15	2.88e-06	181	151	7	9ede19228ba5c0668a9c06c915510b95585216ef
ToppCell	LV-15._Ventricular_Cardiomyocyte_III\|LV / Chamber and Cluster_Paper	FLNC SORBS2 ACACB OBSCN LMOD2 RYR2 TBC1D4	3.21e-06	184	151	7	ab7a1620c14a9d9b6be1b47c559931e345e9eef8
ToppCell	3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-pericyte_cell-Pericytes-Pericytes_L.2.3.3.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	SPARC MYLK MATN3 OBSCN PTEN RYR2 EPB41L2	3.44e-06	186	151	7	888e85a025bd982d36c910db0f5a3385b1ca3b28
ToppCell	Primary_Visual_cortex_(V1C)-Non-neuronal-Macroglial-Oligo-OPC\|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	SPATA6 DISC1 ATP10B TMEM132C NHSL1 PCDH15 FBN3	3.57e-06	187	151	7	daff7ccd3f1924cf2b34d3aca3eccde245aaf371
ToppCell	LPS_only-Epithelial_alveolar-AT_1\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	DSG2 EPB41L3 SHANK2 C3 ERICH2 IRX2 MYRF	3.57e-06	187	151	7	ff26a533d310126521efe1d05cf8b9d32e524550
ToppCell	Primary_Visual_cortex_(V1C)-Non-neuronal-Macroglial-Oligo-OPC-OPC_L1-6_MYT1\|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	SPATA6 DISC1 ATP10B TMEM132C NHSL1 PCDH15 FBN3	3.57e-06	187	151	7	5b7a1edee602e55d3400dc17dbb6b8aaa26defc0
ToppCell	LV-04._Ventricular_Cardiomyocyte_I\|World / Chamber and Cluster_Paper	KLHL24 SORBS2 ACACB NEK10 OBSCN GCNT2 TBC1D4	3.69e-06	188	151	7	0758b474457efa36488e0195f7357100f4b6a090
ToppCell	Fibroblast-E_(Early_Fibroblastic_progenitor)\|World / shred on cell class and cell subclass (v4)	MIS18BP1 HJURP HMMR RRM1 LIG1 FBLN1 MAD2L1	3.69e-06	188	151	7	be3db9768364568f44e32ae6b3bf99e49b0978bb
ToppCell	RV-04._Ventricular_Cardiomyocyte_I\|RV / Chamber and Cluster_Paper	KLHL24 SORBS2 NEK10 OBSCN GCNT2 RYR2 TBC1D4	3.83e-06	189	151	7	9c1debd65c13d63fd4f3158917d621b44b714c26
ToppCell	LPS_only-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	COL6A6 RYR2 TMEM132C FBLN1 PCDH15 LRP1 GULP1	3.83e-06	189	151	7	2a22b9fae70afb3dab8476f9c00e48a4df756410
ToppCell	Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D150\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	CFTR GCNT2 GLCCI1 NHSL1 SHANK2 IRX2 FBN3	3.96e-06	190	151	7	8aea807a2bcf0b653b4de6202b6ecb0f0683cc2e
ToppCell	RV-15._Ventricular_Cardiomyocyte_III\|RV / Chamber and Cluster_Paper	FLNC SORBS2 OBSCN LMOD2 RYR2 MAPK8IP3 DDX60L	3.96e-06	190	151	7	93c3188dfeb0b2f9889f8ae9b9c1f2f34129c99b
ToppCell	PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_adventitial_fibro_(10)\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	FLNC SPARC SORBS2 COL6A6 FBLN1 C3 MYRF	3.96e-06	190	151	7	4f775ee24b14733f06ae40b45f2dc1a0f0df0705
ToppCell	RV-06._Ventricular_Cardiomyocyte_II\|RV / Chamber and Cluster_Paper	KLHL24 SORBS2 ACACB NEK10 OBSCN RYR2 TBC1D4	3.96e-06	190	151	7	fe8e78922c8ae928ef9a80bffd67868d5a87a091
ToppCell	TCGA-Bone_and_Soft_Tissue-Primary_Tumor-Sarcoma\|TCGA-Bone_and_Soft_Tissue / Sample_Type by Project: Shred V9	SPARC CARD8 FBLN1 LRP1	4.07e-06	32	151	4	ba89b22a5ce8ee9f3099b1fa84721724b94c7759
ToppCell	TCGA-Bone_and_Soft_Tissue-Primary_Tumor\|TCGA-Bone_and_Soft_Tissue / Sample_Type by Project: Shred V9	SPARC CARD8 FBLN1 LRP1	4.07e-06	32	151	4	58b212d4f2955f06a195df0f79ad95a8ff145b83
ToppCell	LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	MYLK COL6A6 RYR2 TMEM132C FBLN1 PCDH15 LRP1	4.10e-06	191	151	7	b13229bb7f3713a392271aaf5dbae3edd1b9fe5a
ToppCell	Control-Myeloid\|Control / group, cell type (main and fine annotations)	PSAP DOCK11 DISC1 EPB41L3 LRP1 DDX60L NCKAP1L	4.10e-06	191	151	7	9c4acc5f3c2f9c0c5520863bb22f391774372347
ToppCell	facs-Aorta-Heart-3m-Mesenchymal-fibroblast\|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FLNC TMEM132C SEC24D FBLN1 LRP1 C3 MYRF	4.10e-06	191	151	7	9214655dca96d766737c9f30b624d7fe7050342e
ToppCell	Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	CFTR GCNT2 GLCCI1 NHSL1 SHANK2 MYRF FBN3	4.10e-06	191	151	7	ca5669bd6f4a17471acae3eb229f845cc2e08efa
ToppCell	Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)\|World / Lineage, Cell type, age group and donor	CFTR GCNT2 GLCCI1 MALRD1 SHANK2 IRX2 FBN3	4.10e-06	191	151	7	d3733c8c4bda70c4390e5601fdda6188a64be944
ToppCell	P03-Mesenchymal-developing_mesenchymal_cell-mesenchymal_proliferating_cell\|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	MIS18BP1 HJURP HMMR RRM1 LIG1 FBLN1 MAD2L1	4.10e-06	191	151	7	b978afe76754cc56e1672abca27be289bb56375b
ToppCell	LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	MYLK COL6A6 TMEM132C FBLN1 PCDH15 LRP1 GULP1	4.24e-06	192	151	7	6f4ef24dab544681304b7f8a9dc073e7edaa4cf5
ToppCell	LV-04._Ventricular_Cardiomyocyte_I\|LV / Chamber and Cluster_Paper	KLHL24 SORBS2 ACACB OBSCN GCNT2 RYR2 TBC1D4	4.24e-06	192	151	7	ad19e2c1d36a0566c9b12ced10db78f4781c8ea6
ToppCell	P07-Mesenchymal-developing_mesenchymal_cell-mesenchymal_proliferating_cell\|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	MIS18BP1 HJURP HMMR RRM1 LIG1 FBLN1 MAD2L1	4.24e-06	192	151	7	5ef79faddb433c09ff36660d8bf7a3af5a67bf1d
ToppCell	LPS_only-Stromal_mesenchymal\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	MYLK COL6A6 RYR2 TMEM132C FBLN1 PCDH15 LRP1	4.24e-06	192	151	7	162d8b5858d150ecbbd1c9bf2b19c6c9cd50a158
ToppCell	10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte-C\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	MYLK ATP10B PEX5L NKAIN2 PWWP3A ST18 MYRF	4.24e-06	192	151	7	3ce5dbde41aeb73d49f2c7991d34682f0827fa5a
ToppCell	LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	COL6A6 RYR2 TMEM132C FBLN1 PCDH15 LRP1 GULP1	4.24e-06	192	151	7	deeecd26972241846b4cb998edf0c7a87ff0c4df
ToppCell	3'-Distal_airway-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophages-Alveolar_macrophages_L.1.0.5.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	PSAP CD4 TBC1D4 LRP1 ZFYVE26 DDX60L NCKAP1L	4.39e-06	193	151	7	222829c30ebe47f0ed1e035897e3cd4be10b2a11
ToppCell	PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_adventitial_fibro_(10)\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	SPARC SORBS2 COL6A6 DOCK11 FBLN1 C3 MYRF	4.39e-06	193	151	7	adc9fc94f9ec686a417d08c0b8b7b7ab687afec0
ToppCell	Mesenchymal-matrix_fibroblast_1_cell\|World / Lineage, Cell type, age group and donor	MYLK COL6A6 NKAIN2 RYR2 TMEM132C FBLN1 PCDH15	4.39e-06	193	151	7	acad568621ed677031797b8c2e34dafea798d681
ToppCell	Fetal_29-31_weeks-Epithelial\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	CFTR GCNT2 GLCCI1 SHANK2 IRX2 MYRF FBN3	4.39e-06	193	151	7	a0ca3231992f14abcf1a6129573bace320e89d2a
ToppCell	Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	MYLK SPATA6 NKAIN2 RYR2 TMEM132C FBLN1 PCDH15	4.54e-06	194	151	7	011e14d9ed1393275f892060e7708ffadcd0767f
ToppCell	Children_(3_yrs)-Immune-alveolar_macrophage_(MARCO_positive)\|Children_(3_yrs) / Lineage, Cell type, age group and donor	MIS18BP1 PSAP DOCK11 TEX2 LRP1 DDX60L NCKAP1L	4.54e-06	194	151	7	69cf7c989ac355c459db13f9d4267b55adc3c174
ToppCell	LPS-antiTNF-Stromal_mesenchymal\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	MYLK COL6A6 RYR2 TMEM132C FBLN1 PCDH15 LRP1	4.54e-06	194	151	7	6e13549f697f7478b34fe71f7dd9d63c5d3db22e
ToppCell	(5)_Fibroblast-C_(Myofibroblast)\|World / Lung cell shreds - cell class (v4) and cell subclass (v4)	SPARC MYLK COL6A6 TMEM132C FBLN1 KCNS3 GULP1	4.54e-06	194	151	7	29a72e565c19407bbd198cfbc2a78106fe830d05
ToppCell	LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	MYLK COL6A6 TMEM132C FBLN1 PCDH15 LRP1 GULP1	4.54e-06	194	151	7	89b706af2b25991fc2707eb24f49ba6ff3ae01f7
ToppCell	IPF-Multiplet-Multiplet\|World / Disease state, Lineage and Cell class	SORBS2 ZCWPW2 NEK10 SHANK2 ZMYND10 TTC29 OSBPL6	4.70e-06	195	151	7	21dbdc803c6947024dc2416e9e21c2ef0af9bc31
ToppCell	5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.0\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	SERPINA3 MYLK COL6A6 RYR2 FBLN1 PCDH15 LRP1	4.70e-06	195	151	7	df409f94f4e83be89f7a608058ee07ce3ce3a149
ToppCell	5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	SERPINA3 MYLK COL6A6 RYR2 FBLN1 PCDH15 LRP1	4.70e-06	195	151	7	4243190ad291d56694e2155954dbaa879c9d3844
ToppCell	5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	SERPINA3 SPARC MYLK COL6A6 FBLN1 PCDH15 LRP1	4.86e-06	196	151	7	42e9828222a9663525d571633e8a454c30bfa7f8
ToppCell	LPS_only-Endothelial-Endothelial-FOXM1\|LPS_only / Treatment groups by lineage, cell group, cell type	MIS18BP1 DISC1 HMMR RRM1 OSBPL6 KDM1A MAD2L1	5.02e-06	197	151	7	038fd92750257d43d5e980fd06d77742b543f11a
ToppCell	facs-Trachea-nan-3m-Mesenchymal-fibroblast\|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SPARC NEDD4 SEC24D FBLN1 LRP1 C3 EPB41L2	5.19e-06	198	151	7	0dc7d59a07428a7b7e8bdc81f0e2417dd4ce3cf2
ToppCell	PSB\|World / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	SPATA6 CFTR STOX1 TTC29 OSBPL6 IRX2 GULP1	5.19e-06	198	151	7	4e6b0d1abc55d7a0d89bd7ecf0f13dc5bed66626
ToppCell	Fetal_29-31_weeks-Mesenchymal\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	SPARC MYLK COL6A6 RYR2 TMEM132C FBLN1 EPB41L2	5.19e-06	198	151	7	21cf4d81386761d09d0f6829c01c198e5524176d
ToppCell	Mesenchymal\|World / Lineage, Cell type, age group and donor	SPARC MYLK COL6A6 RYR2 TMEM132C FBLN1 EPB41L2	5.37e-06	199	151	7	4bac110c2b3609f6ee5d0e3275da0824a6240270
ToppCell	Biopsy_Control_(H.)-Mesenchymal-Mesothelial_cells\|Biopsy_Control_(H.) / Sample group, Lineage and Cell type	FLNC DPYS ATP10B PEX5L FBLN1 C3 MYRF	5.37e-06	199	151	7	ca970114b5aef4518ce580897a62ac88688b2671
ToppCell	COVID-19-lung\|COVID-19 / Disease (COVID-19 only), tissue and cell type	PSAP DOCK11 RNF213 BAZ1A LRP1 IFI44L NCKAP1L	5.37e-06	199	151	7	155b03b859157013e9142e9248551369127d9204
ToppCell	LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	COL6A6 RYR2 TMEM132C FBLN1 PCDH15 LRP1 C3	5.37e-06	199	151	7	8b86c69aaf60feff53aa782559cfece7342a23de
ToppCell	Parenchymal-NucSeq-Immune_Myeloid\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	PSAP DOCK11 DISC1 PPARGC1B LRP1 DDX60L NCKAP1L	5.37e-06	199	151	7	7ee2805fd9143eba11bf6832267b62189683608b
ToppCell	Control_saline-Mesenchymal_fibroblastic\|Control_saline / Treatment groups by lineage, cell group, cell type	MYLK COL6A6 MATN3 TMEM132C FBLN1 PCDH15 LRP1	5.55e-06	200	151	7	64ae5cf6cb4fc94cf1052abd82648f6b8e6445fe
ToppCell	Parenchyma_Control_(B.)-Stromal-TX-Fibroblasts-1\|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type	SPARC MYLK COL6A6 RYR2 FBLN1 PCDH15 EPB41L2	5.55e-06	200	151	7	aa1a35dcca3b799241eef4237f6eb94660e019f0
ToppCell	mild-Non-classical_Monocyte\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	MIS18BP1 SPATA6 EPB41L3 PPARGC1B LRP1 C3 EPB41L2	5.55e-06	200	151	7	334bab6bf93d455f3526e817ea5785d8b6ee531c
ToppCell	Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Fibroblasts-1\|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)	SPARC MYLK COL6A6 RYR2 FBLN1 PCDH15 EPB41L2	5.55e-06	200	151	7	a510deaada669e690329183e18df02870bd204b3
ToppCell	Bronchial-NucSeq-Stromal-Fibroblastic\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	MYLK COL6A6 RYR2 TMEM132C FBLN1 LRP1 EPB41L2	5.55e-06	200	151	7	cae972324d1dfea6efeaf6013f265c7c6bb48db4
ToppCell	Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_alveolar\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	MYLK COL6A6 TMEM132C FBLN1 LRP1 C3 EPB41L2	5.55e-06	200	151	7	3dd022e974fec7013ba18f333da63f58fbf2dd7c
ToppCell	Control_saline-Mesenchymal_myocytic-Pericyte\|Control_saline / Treatment groups by lineage, cell group, cell type	MYLK COL6A6 DOCK11 RYR2 LRP1 KCNS3 EPB41L2	5.55e-06	200	151	7	cb7ef774b6d300f8019c5b16a04e3ebd165e4f1c
ToppCell	Control_saline-Mesenchymal_fibroblastic-Fibroblasts\|Control_saline / Treatment groups by lineage, cell group, cell type	MYLK COL6A6 MATN3 TMEM132C FBLN1 PCDH15 LRP1	5.55e-06	200	151	7	a1fc74c1b27e104895910bc7cdce7ba33d30df7e
ToppCell	3'-GW_trimst-1.5-SmallIntestine-Mesenchymal-immature_mesenchymal_cell-cycling_stromal\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	MIS18BP1 HJURP HMMR RRM1 LIG1 POLD3 MAD2L1	5.55e-06	200	151	7	38665128b54f4a81b53c961427aed67bf4e2510b
ToppCell	Control_saline-Mesenchymal_myocytic-Pericyte-Pericyte_2\|Control_saline / Treatment groups by lineage, cell group, cell type	MYLK COL6A6 DOCK11 RYR2 LRP1 KCNS3 EPB41L2	5.55e-06	200	151	7	bc8949eb34482aca166c4602ff6ab876cb4c2c3c
ToppCell	Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Fibroblasts-1-\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	SPARC MYLK COL6A6 RYR2 FBLN1 PCDH15 EPB41L2	5.55e-06	200	151	7	dd4228cbed8a4395166a6332e08d44d88bebe3b9
ToppCell	LPS-antiTNF-Epithelial_alveolar-Mes-Like-AT2_Progenitor\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	HJURP HMMR KCNRG OSBPL6 C3 IRX2	1.29e-05	151	151	6	c06a54afe918b14f885d6a85fbcf81e80f33afae
ToppCell	LPS-IL1RA-Stromal_mesenchymal-Fibroblasts-Pericyte_2\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ZCWPW2 NEK10 RYR2 TXNRD3 PCDH15 HSF2	1.67e-05	158	151	6	7f5426585d0d299d2b48e5fcb349950feffdef33
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-MG\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	TLR10 CD4 C3 IFI44L EPB41L2 NCKAP1L	2.28e-05	167	151	6	942134bbabe9972fae80cbc4ed4e94da52f55dc3
ToppCell	3'-Adult-SmallIntestine-Epithelial-epithelial_progenitor_cell\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	ACACB GCNT2 KCNRG NEDD4 MALRD1 MTREX	2.36e-05	168	151	6	4e2e4c88ada772e9ba6e72c9ae3a05c063e93318
ToppCell	3'-Adult-SmallIntestine-Epithelial-epithelial_progenitor_cell-TA\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	ACACB GCNT2 KCNRG NEDD4 MALRD1 MTREX	2.36e-05	168	151	6	ee4dab089adef2f47a9d39d91934523331a8b81c
ToppCell	Dividing_Macrophages-IPF_04\|World / lung cells shred on cell class, cell subclass, sample id	MIS18BP1 HJURP HMMR RRM1 PNPLA1 MAD2L1	2.44e-05	169	151	6	bc859a103cad567caf50c3c3882d2d2017807c73
ToppCell	droplet-Lung-1m-Hematologic-myeloid-myeloid_dendritic_cell-proliferating_dendritic\|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	TTLL9 HMMR LIG1 RAB43 NECAB3 MAD2L1	2.52e-05	170	151	6	badbe200e9d5003d23d115955b10b4ea767f6c26
ToppCell	PND07-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-ASMC-ASMC_mature\|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	FLNC SORBS2 MYLK OBSCN LMOD2 RYR2	2.52e-05	170	151	6	cb1ed6bd409ee1cf11be0d5e7cdcffe2ab220d38
ToppCell	PND07-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-ASMC\|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	FLNC SORBS2 MYLK OBSCN LMOD2 RYR2	2.52e-05	170	151	6	da4fb1e186e9bec6bba0b25f2a0e68f9e11c6017
ToppCell	Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D046\|Children_(3_yrs) / Lineage, Cell type, age group and donor	GCNT2 GLCCI1 NHSL1 MALRD1 SHANK2 IRX2	2.78e-05	173	151	6	b799c06a6a5754668e789f70c0c8bc1508568575
ToppCell	PND14-Immune-Immune_Myeloid-DC-cDC1-cDC1_prolif\|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	RRM1 LIG1 TBC1D4 BAZ1A RAB43 NCKAP1L	2.87e-05	174	151	6	09b091e24317c3f7bac043f04762a533e30793de
ToppCell	droplet-Lung-18m-Hematologic-myeloid-myeloid_dendritic_cell-proliferating_dendritic\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	MIS18BP1 HMMR LIG1 NECAB3 TTC39A MAD2L1	2.97e-05	175	151	6	a6913f992a1ea20b43e5adeca3ede3a6fda820ad
ToppCell	COVID-19-Heart-CM_3\|COVID-19 / Disease (COVID-19 only), tissue and cell type	FLNC SORBS2 OBSCN LMOD2 RYR2 DDX60L	3.06e-05	176	151	6	9df7a124ebafb0087da0cda133a394275d7bed81
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	ZNF423 RYR2 TMEM132C FBLN1 C3 EPB41L2	3.16e-05	177	151	6	9ec7f1e64312d26d434b3312b58386715dbad644
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	ZNF423 RYR2 TMEM132C FBLN1 C3 EPB41L2	3.16e-05	177	151	6	016277dfd59b1793fddaaadc2b3f41622d76ce3a
ToppCell	3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-pericyte_cell-Pericytes-Pericytes_L.2.3.1.1\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	SPARC MYLK MATN3 RAD51AP2 KCNQ4 EPB41L2	3.16e-05	177	151	6	452ec2df36c6d656a7cdadc55be545ccdb146a29
ToppCell	facs-Pancreas-Exocrine-3m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	COL6A6 USP9X PEX5L RAD51AP2 SEC24D ST18	3.26e-05	178	151	6	fcbbcc44271515de1969b4732b6441c012693d5f
ToppCell	droplet-Marrow-nan-3m-Lymphocytic\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FBXL13 TEX2 NEDD4 SEC24D CD4 TBC1D4	3.37e-05	179	151	6	dcaf2191134a586d50ebaf67dcf5b815b54a722b
ToppCell	PND28-Immune-Immune_Myeloid-DC-cDC1-cDC1_prolif\|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	RRM1 LIG1 TBC1D4 RAB43 TTC39A PUS7L	3.37e-05	179	151	6	9dea57494d59abd6e8abf34e31faf53462ea0fa0
Disease	Long QT Syndrome	CYP1A1 PTEN RYR2	1.94e-05	11	147	3	C0023976
Disease	Peripheral Vascular Diseases	DAB2IP CYP1A1	2.47e-05	2	147	2	C0085096
Disease	mean arterial pressure, response to cold pressor test	FBXL13 TRPM8	7.37e-05	3	147	2	EFO_0005404, EFO_0006340
Disease	systolic blood pressure, response to cold pressor test	FBXL13 TRPM8	1.47e-04	4	147	2	EFO_0005404, EFO_0006335
Disease	inflammatory bowel disease (implicated_via_orthology)	EPB41L3 EPB41L1 EPB41L2	2.57e-04	25	147	3	DOID:0050589 (implicated_via_orthology)
Disease	chronic obstructive pulmonary disease (is_implicated_in)	CYP1A1 SERPINA3 CFTR XRCC5	2.80e-04	63	147	4	DOID:3083 (is_implicated_in)
Disease	cystic fibrosis (is_implicated_in)	CYP1A1 SERPINA3 CFTR	3.25e-04	27	147	3	DOID:1485 (is_implicated_in)
Disease	Clear cell sarcoma of kidney	YWHAE IRX2	3.65e-04	6	147	2	C0334488
Disease	renal transplant outcome measurement	SHANK2 TRAV19	3.65e-04	6	147	2	EFO_0005199
Disease	brain disease (implicated_via_orthology)	PTEN TIAM2	3.65e-04	6	147	2	DOID:936 (implicated_via_orthology)
Disease	brain measurement, hippocampal volume	MALRD1 UTP20	3.65e-04	6	147	2	EFO_0004464, EFO_0005035
Disease	Intellectual Disability	DISC1 PTEN MAPK8IP3 SHANK2 SMARCD1 TAF1 EPB41L1 RAI1 HTT	4.23e-04	447	147	9	C3714756
Disease	Melanoma, Cloudman S91	PTEN KDM1A	5.09e-04	7	147	2	C0009075
Disease	Common Migraine	LRP1 TRPM8	5.09e-04	7	147	2	C0338480
Disease	Melanoma, B16	PTEN KDM1A	5.09e-04	7	147	2	C0004565
Disease	Melanoma, Experimental	PTEN KDM1A	5.09e-04	7	147	2	C0025205
Disease	Melanoma, Harding-Passey	PTEN KDM1A	5.09e-04	7	147	2	C0018598
Disease	Developmental Coordination Disorder	DISC1 PTEN	6.77e-04	8	147	2	C0011757
Disease	Motor Skills Disorders	DISC1 PTEN	6.77e-04	8	147	2	C0026613
Disease	Acute Confusional Migraine	LRP1 TRPM8	8.67e-04	9	147	2	C0521664
Disease	Status Migrainosus	LRP1 TRPM8	8.67e-04	9	147	2	C0338489
Disease	Abdominal Migraine	LRP1 TRPM8	8.67e-04	9	147	2	C0270858
Disease	Sick Headaches	LRP1 TRPM8	8.67e-04	9	147	2	C0700438
Disease	Cervical Migraine Syndrome	LRP1 TRPM8	8.67e-04	9	147	2	C0007852
Disease	Hemicrania migraine	LRP1 TRPM8	8.67e-04	9	147	2	C0018984
Disease	migraine disorder, Headache	HJURP RNF213 LRP1 TRPM8	9.15e-04	86	147	4	HP_0002315, MONDO_0005277
Disease	coronary artery disease	DAB2IP CYP1A1 SORBS2 PSAP CFTR RNF213 DMXL1 MAPK8IP3 NEDD4 MALRD1 TTC29 LRP1 KCNS3 MAD2L1 RAI1	9.43e-04	1194	147	15	EFO_0001645
Disease	Malignant neoplasm of breast	CYP1A1 DDX59 B3GALNT2 OBSCN HMMR PTEN EPB41L3 NEDD4 RGL1 PPARGC1B ZNF644 SMARCD1 UTP20 ZFYVE26	9.86e-04	1074	147	14	C0006142
Disease	Moyamoya disease	RNF213 LRP1 MYRF	1.05e-03	40	147	3	MONDO_0016820
Disease	valine measurement	ACACB ARMC2 MALRD1	1.05e-03	40	147	3	EFO_0009792
Disease	anti-topoisomerase-I-antibody-positive systemic scleroderma	TLR10 IFT122	1.08e-03	10	147	2	EFO_0008537
Disease	Cognitive impairment	RYR2 DMXL1	1.32e-03	11	147	2	HP_0100543
Disease	Occupational Diseases	CYP1A1 CARD8	1.32e-03	11	147	2	C0028797
Disease	Methionine sulfoxide measurement	TMEM132C CD4	1.57e-03	12	147	2	EFO_0021650
Disease	response to bronchodilator, FEV/FEC ratio	SPARC ATG2A YWHAE TMEM132C SHANK2 RAB43 TTC29 LPO PCDH15 ERICH2 GULP1	1.63e-03	766	147	11	EFO_0004713, GO_0097366
Disease	esophageal cancer (is_implicated_in)	CYP1A1 PTEN	1.85e-03	13	147	2	DOID:5041 (is_implicated_in)
Disease	Migraine Disorders	LRP1 TRPM8	1.85e-03	13	147	2	C0149931
Disease	Thyroid Diseases	CNST GULP1	1.85e-03	13	147	2	C0040128
Disease	dystonia (is_implicated_in)	KMT2B TSPOAP1	2.16e-03	14	147	2	DOID:543 (is_implicated_in)
Disease	renal cell carcinoma (biomarker_via_orthology)	CYP1A1 PTEN	2.16e-03	14	147	2	DOID:4450 (biomarker_via_orthology)
Disease	Anilide use measurement	LRP1 TRPM8	2.48e-03	15	147	2	EFO_0009938
Disease	response to peritoneal dialysis, peritoneal solute transfer rate	SERTAD2 BAZ1A	2.48e-03	15	147	2	EFO_0600089, EFO_0600090
Disease	Colorectal Carcinoma	FLNC SPARC CFTR OBSCN PTEN PEX5L LIG1 LRP1 POLD3 EDRF1	2.80e-03	702	147	10	C0009402
Disease	migraine without aura, susceptibility to, 4	LRP1 TRPM8	2.83e-03	16	147	2	MONDO_0011847
Disease	facial pigmentation measurement	SORBS2 HJURP PPARGC1B	2.91e-03	57	147	3	EFO_0006942
Disease	major depressive disorder (is_marker_for)	DISC1 PTEN	3.19e-03	17	147	2	DOID:1470 (is_marker_for)
Disease	Insulin Resistance	ACACB PTEN C3	3.37e-03	60	147	3	C0021655
Disease	Insulin Sensitivity	ACACB PTEN C3	3.37e-03	60	147	3	C0920563
Disease	Adrenocortical carcinoma	SPARC RRM1	3.58e-03	18	147	2	C0206686
Disease	behavior or behavioral disorder measurement, personality trait	FBLN1 KCNS3	3.58e-03	18	147	2	EFO_0004365, EFO_0004782
Disease	sexual dimorphism measurement	KMT2B KCTD19 MATN3 R3HCC1 RGPD1 ARMC2 PNPLA1 RAB43 ERICH2 MAPKBP1 MYRF EPB41L1 EPB41L2	3.65e-03	1106	147	13	EFO_0021796
Disease	blood arsenic measurement	SORBS2 NKAIN2	3.99e-03	19	147	2	EFO_0021527
Disease	Cannabis use, age at onset	ZNF423 RYR2	3.99e-03	19	147	2	EFO_0004847, EFO_0007585
Disease	arterial stiffness measurement	DAB2IP NEK10 DISC1	4.04e-03	64	147	3	EFO_0004517
Disease	Headache	RNF213 LRP1 TRPM8	4.04e-03	64	147	3	HP_0002315
Disease	Global developmental delay	MAPK8IP3 SMARCD1 TAF1 KDM1A	4.48e-03	133	147	4	C0557874
Disease	Antimigraine preparation use measurement	LRP1 TRPM8	4.86e-03	21	147	2	EFO_0009939

Protein segments in the cluster

Peptide	Gene	Start	Entry
DAIAELDTLSEESYK	YWHAE	201	P62258
EYCLQDIDDKLSESA	ERICH2	26	A1L162
GYLDVLTEKEIFESC	CFTR	576	P13569
DEELSCTVVELKYTG	SERPINA3	256	P01011
KCEVFDDEEESKLTY	CFAP36	36	Q96G28
TTLEYKSLDDCEELV	ARMC2	636	Q8NEN0
IYLDKVSHSEDDCLA	C3	1446	P01024
CSTEDLLYDRDKDSG	GLCCI1	381	Q86VQ1
SEKYSCSEEILTVAA	DHX16	831	O60231
TPDKEELLSSEACYE	FBN3	2661	Q75N90
EDEENESICTTKYLE	CCDC172	186	P0C7W6
SYILSAELGEKCEDI	DISC1	771	Q9NRI5
LLAADDDSCYSSLEK	DMXL1	1411	Q9Y485
FILDDSALYLSDKCE	ATG2A	1156	Q2TAZ0
SALYLSDKCEVETLD	ATG2A	1161	Q2TAZ0
DLDLYDEETDLSIQC	ATP10B	401	O94823
CEYKLASEFIDDIEL	BAZ1A	1486	Q9NRL2
EDDDICNVTISDLYA	HJURP	251	Q8NCD3
SSCSEDDYSELLQEI	R3HCC1	271	Q9Y3T6
SEEELLYSTSEKDCE	RAD51AP2	1071	Q09MP3
RKEDLEAEEEYSSLC	RAI1	861	Q7Z5J4
EHYDILCAIETSAKD	RAB43	151	Q86YS6
LTEEESYALSCEIEA	RGL1	486	Q9NZL6
SPKCLEISIEYDSED	TSPOAP1	1491	O95153
SCYLEEHVSKEAEVL	CYP1A1	156	P04798
ETISEVYELCAFLDK	KCTD19	341	Q17RG1
ITKERDYCAEDQTIE	LEMD1	131	Q68G75
EARTSLYSEDDCKSL	ACACB	1401	O00763
TAKDCLLVYSQEETE	DSG2	791	Q14126
YADTLISRESCEKSE	PCDHGA4	806	Q9Y5G9
LEEYETLFKCQEETT	DAB2IP	1056	Q5VWQ8
VTLLDASEYECEVEK	EPB41L1	101	Q9H4G0
SLIISDVCGDDDAKY	MYLK	1866	Q15746
DLDQIDYIDSCTAEE	LRCH3	371	Q96II8
DTCLVYDIDTKELLF	IFT122	536	Q9HBG6
YTLNEDKKTCSATEE	MATN3	421	O15232
EVSCSFDLLIYTDKD	MAD2L1	146	Q13257
TTTYDFDCDNLELKS	MIS18BP1	521	Q6P0N0
EPKEEAEDVSSYLCT	MAPK8IP3	496	Q9UPT6
AEDVSSYLCTESDKI	MAPK8IP3	501	Q9UPT6
LADSDDASFTCILKD	NEDD4	106	P46934
DLTTLCEETEDKYQN	EDRF1	436	Q3B7T1
TENALKTTLDEATCY	GCNT2	61	Q8N0V5
LYFSDATLDKIERCE	LRP1	2391	Q07954
IAYVALLTKVDDCSE	IFI44L	351	Q53G44
TDLELYEAFSRCKEI	DPYS	171	Q14117
VAEEKSYQCELTVDD	KCNQ4	511	P56696
SKYESIDEDELLASL	LMOD2	11	Q6P5Q4
EYICDKTDEDVCSLE	DDX59	116	Q5T1V6
NLKILEISEDCTYAD	DDX60L	1191	Q5H9U9
EISEDCTYADVKALH	DDX60L	1196	Q5H9U9
KVTLLDGTEYSCDLE	EPB41L2	221	O43491
YQDEDEETDQKCSLS	NHSL1	151	Q5SYE7
SYGKDEDRACDEILS	NEK10	871	Q6ZWH5
YDFVDCSAIDKLDLS	LPO	691	P22079
SIDDFLCETKSEAIA	PEX5L	81	Q8IYB4
VEECYVSELDSDKHT	FLNC	2451	Q14315
CFYLEAGDLSKETDL	NKAIN2	81	Q5VXU1
KDSDLCELSLLYAEL	NRDE2	816	Q9H7Z3
SEFTSKEELIEALYC	PNPLA1	136	Q8N8W4
DTSSPEEEYKVACLL	NCKAP1L	986	P55160
EAILELCDDYSVADK	KCNS3	51	Q9BQ31
AKCEGLSDEDYEILS	KMT2B	1366	Q9UMN6
VSSEDKTECYSFERI	KCNRG	231	Q8N5I3
LDDCAETLEDLDLSY	LRFN3	151	Q9BTN0
EDVLESFYSIDCIKS	PAXBP1	586	Q9Y5B6
ESSTDYTKLQEEFCL	OSBPL6	366	Q9BZF3
ESGSECKDKYDDLED	IRX2	251	Q9BZI1
FCSSDEELEDSKALL	RBBP5	386	Q15291
CLAERASYSESEVKD	OBSCN	7756	Q5VST9
EKLLEYIEEISCASD	HMMR	231	O75330
GYELTEDNSCKDIDE	FBLN1	251	P23142
KDNYCIISSSEESEL	FAM9A	316	Q8IZU1
LDDISVSQECEISYK	MALRD1	626	Q5VYJ5
DAFSLEDYTKCDLTV	PCDH15	1296	Q96QU1
STLSTYLEDCKFDRE	COMMD3	81	Q9UBI1
VLYVLECDLLDDTAK	HTT	2786	P42858
TEDGLKAVITCYDTE	KLHL11	516	Q9NVR0
DLTALCKEYDELAET	KDM1A	486	O60341
ELDKDELIDYICSDE	KLHL24	206	Q6TFL4
RDSDESDASALKCIY	DOCK11	671	Q5JSL3
LLLKTDDDCYIDLEA	B3GALNT2	351	Q8NCR0
DDYDKTCLESALVGV	INTS14	81	Q96SY0
YVFDSEKCAEEITLT	GULP1	126	Q9UBP9
SEQCCYDDAILSLKE	IGFL3	51	Q6UXB1
VSSYASKVCFEIEED	CARD8	141	Q9Y2G2
IEDSDTYICEVEDQK	CD4	101	P01730
LKELSVSECYRITDD	FBXL13	556	Q8NEE6
SDDFCKEKTEDRYSL	MARCHF4	136	Q9P2E8
KVEAHDSEILCLEYS	MAPKBP1	516	O60336
CESEKLLLYDTVQSE	BRMS1L	146	Q5PSV4
LQESSDTEKTAYEKC	CCDC168	4006	Q8NDH2
DLDIESQTCASDYLL	DCBLD1	86	Q8N8Z6
ASYDEDSEELQAICK	LIG1	781	P18858
LLSCAETDENETLDY	RYR2	4066	Q92736
LLDGSEYTCDVEKRS	EPB41L3	116	Q9Y2J2
LLEGCLKDTEDSLSY	CNST	551	Q6PJW8
KSGCVDTEEADIYLL	COL6A6	426	A6NMZ7
DSICSIERADNDKEY	PTEN	301	P60484
TLKEYLESLQCLESD	RGPD1	201	P0DJD0
GKVELLDYLDSIDCS	HSF2	356	Q03933
DSVTEDDICFKVLYD	PLA2G4D	96	Q86XP0
CAISAVDEVDYKTAE	PWWP3A	666	Q2TAK8
KEKLSTCEAEDIATY	MRPS27	361	Q92552
VDEEEKEYTCKSLSD	UTP20	1721	O75691
SYDTLCVLDGDKDSV	USP9X	826	Q93008
LEKEDGSILICLYES	TLR10	656	Q9BXR5
KTACYDIDVEVDDTL	SMARCD1	386	Q96GM5
STDEDVIKVSERCDY	TMEM132C	476	Q8N3T6
LEYKELCHLVSEEEA	PUS7L	201	Q9H0K6
EYDEHLTQLEKDICT	TAF1	1606	P21675
LETALEEEDLASCKS	PPARGC1B	771	Q86YN6
VDKLEQIYECTDTED	WIPI2	61	Q9Y4P8
TEKVYESESCTDSEE	POLD3	401	Q15054
SCYQDDDSVLESLVE	RANBP6	236	O60518
SVFEALDSALKDICD	SORBS2	726	O94875
DDAVYELDGKELCSE	SRSF5	51	Q13243
SQLADLYKSCETDAL	SEC24D	771	O94855
YDSFDTSSDCIIEEK	SHANK2	611	Q9UPX8
SLKAESDEADECFLI	ST18	156	O60284
ADEISECYHKLDSLT	CLCC1	61	Q96S66
EKVAATLEYLDLDDC	PRAMEF6	346	Q5VXH4
TLEYLDLDDCGIIDS	PRAMEF6	351	Q5VXH4
NCLEDSILEKTSAYS	RNF213	4176	Q63HN8
LPKDYCSTDLDLDTE	RNF213	4851	Q63HN8
ELVDTEKSYVKDLSC	TIAM2	1106	Q8IVF5
SAEAKLEIDEETYLS	MTREX	946	P42285
SNLCTEIVEYTSKDE	RRM1	426	P23921
KDSFSSALDEIEELC	SERTAD2	166	Q14140
ACSSLYLEEDDISEN	STOX1	731	Q6ZVD7
ETCDLDNDKYIALDE	SPARC	271	P09486
HKTTISDLAYCEEVE	WDR97	291	A6NE52
YRCTTEAEQDIEEEK	RELL1	86	Q8IUW5
EKVAATLEYLDLDDC	PRAMEF5	346	Q5TYX0
TLEYLDLDDCGIIDS	PRAMEF5	351	Q5TYX0
SIEEYAALDDDLETC	TIGD4	416	Q8IY51
ATEEEILVYLEKTCD	PSAP	81	P07602
KEDVTLDCVYETRDT	TRAV19	36	A0A0A6YYK7
YSCEDSETLEKLERA	TBC1D4	1191	O60343
ESALEVVRKYCEDES	SYMPK	676	Q92797
DVSKITRYTEDCFSD	ZNF644	296	Q9H582
ACIAETLTKNYEDER	TOPAZ1	1321	Q8N9V7
QEDYELKTCLLEDTL	TTLL9	351	Q3SXZ7
VLDTYCKISTDLDDD	TTC29	296	Q8NA56
GDKEYCITSDDLFSL	TXNRD3	316	Q86VQ6
VCESAEDTVLDLVDY	ZMYND10	126	O75800
DYCEDTFSQTEELEK	ZNF423	266	Q2M1K9
YSDDALSKENRVVCE	ZCWPW2	251	Q504Y3
ECYSSDEDLAEQLLV	TRPM8	631	Q7Z2W7
SLSALVSKEDEEFCE	TEX2	406	Q8IWB9
ENEYSVDDECLVKLL	TTC39A	496	Q5SRH9
SQDLALCDSYISKVD	ZFYVE26	1996	Q68DK2
RDFDDSLEKCEEYLS	SPATA6	311	Q9NWH7
VRVCDSCYDSIKDED	WDFY1	341	Q8IWB7
SCYDSIKDEDRTSLA	WDFY1	346	Q8IWB7
KETVYCLNDDDETEV	XRCC5	291	P13010
SILEEYISKEDASDL	MYRF	31	Q9Y2G1
LTDNLETEKLCDYFS	NECAB3	86	Q96P71